GPhA names Ralph Neas president and CEO
This article was originally published in Scrip
The Generic Pharmaceutical Association, which represents the world's leading generic drug manufacturers and suppliers, has named Ralph Neas president and CEO, effective 12 September 2011. Mr Neas most recently served as president and CEO of the National Coalition on Health Care, leading the group's efforts to improve healthcare in the US. GPhA intends to introduce Neas to stakeholders throughout September to renew its participation in the healthcare debate.
You may also be interested in...
Almirall has launched its irritable bowel syndrome drug Constella (linaclotide) in six European countries, with several other launches planned for later this year.
Dermira, a dermatology-focused biotech, has raised $35m in a series B financing.
Clovis Oncology has raised its public offering, announced 11 June, from $170m to $240m.